SCHEMBL9238577

SCHEMBL9238577

COc1cccc2c1CC(CCCNCCNC(=O)Nc1ccccc1)CC2

nearest known ligand 0.48

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 7/20 0.48
MTNR1B P49286 7/20 0.48
SIGMAR1 Q99720 5/20 0.47
CHRM2 P08172 1/20 0.45
CHRM1 P11229 1/20 0.45
CHRM3 P20309 1/20 0.45
CYP1A2 P05177 1/20 0.44
MAPT P10636 1/20 0.44
CYP2C9 P11712 1/20 0.44
ALOX15 P16050 1/20 0.44
HTR1A P08908 1/20 0.43
EPHX2 P34913 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9237392 0.99 MTNR1A (0.47) MTNR1AMTNR1BSIGMAR1CHRM2CHRM1
SCHEMBL9240092 0.81 MTNR1A (0.50) MTNR1AMTNR1BSIGMAR1CHRM2CHRM1
SCHEMBL3732776 0.81 SIGMAR1 (0.54) MTNR1AMTNR1BSIGMAR1CHRM2CHRM1
Hydrochloric Acid SCHEMBL9238517 0.80 MTNR1A (0.49) MTNR1AMTNR1BSIGMAR1CHRM2CHRM1
SCHEMBL8970307 0.75 MTNR1A (0.62) MTNR1AMTNR1BSIGMAR1CHRM2CHRM1
SCHEMBL8970407 0.74 SIGMAR1 (0.53) MTNR1AMTNR1BSIGMAR1CHRM2CHRM1
SCHEMBL2051475 0.74 ALDH1A1 (0.49) MTNR1AMTNR1BCHRM2CHRM1CHRM3
SCHEMBL12635378 0.73 CHRM2 (0.62) MTNR1AMTNR1BSIGMAR1CHRM2CHRM1
SCHEMBL12634890 0.72 CHRM2 (0.60) MTNR1AMTNR1BSIGMAR1CHRM2CHRM1
SCHEMBL8972304 0.71 MTNR1A (0.49) MTNR1AMTNR1BCHRM2CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5463105-A Therapy for cardiovascular, nervous system disorders BAYER AKTIENGESELLSCHAFT (DE) 1995-10-31 US disclosed
US-5298513-A Serotonin antagonist BAYER AKTIENGESELLSCHAFT (DE) 1994-03-29 US disclosed
US-5153225-A For treating disorders of the central nervous system, cardiovascular system and intestinal tract BAYER AKTIENGESELLSCHAFT (DE) 1992-10-06 US disclosed
US-5026857-A Cetnral nervous system disorders; antiserotonine agent BAYER AKTIENGESELLSCHAFT (DE) 1991-06-25 US disclosed
US-4880802-A CENTRAL NERVOUS SYSTEM BAYER AKTIENGESELLSCHAFT (DE) 1989-11-14 US disclosed